Co-Diagnostics, Inc. CODX 深 沪
等待开盘 04-02 09:30:00 美东时间
1.68
-0.180
-9.68%
华盛通- 最 高1.735
- 今 开1.72
- 成交量 18.16万股
- 最 低 1.52
- 昨 收 1.86
- 总市值 351.97万
- 52周最高 3.95
- 市盈率 静 --
- 换手率 8.67%
- 52周最低 1.52
- 委 比 -78.76%
- 总股本 209.50万
- 历史最高 3.95
- 量 比 0.27
- 振 幅 11.56%
- 历史最低 1.52
- 每 手 1
- 风险率 0.64%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Co-Diagnostics Q4 EPS $(16.65) Down From $(10.82) YoY, Sales $263.922K Up From $149.325K YoY
Co-Diagnostics (OTC:CODX) reported quarterly losses of $(16.65) per share. This is a 53.88 percent decrease over losses of $(10.82) per share from the same period last year. The company reported $263.922 thousand in
04-01 04:07
Earnings Scheduled For March 31, 2026
Companies Reporting Before The Bell • Bitfarms (NASDAQ:BITF) is projected to re...
03-31 19:11
EXCLUSIVE: Co-Diagnostics Ships Diagnostic Tests To India Ahead Of TB Study Launch
Co-Diagnostics ships PCR Pro and TB test kits to India, advancing clinical studies as the WHO backs NPOC diagnostics.
03-25 19:46
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Azitra (AMEX:AZTR) stock moved upwards by 87.3% to $0.33 during Friday...
03-20 20:05
EXCLUSIVE: Co-Diagnostics Expands South Asia Reach, Targets $13 Billion Market Opportunity
Co-Diagnostics expands CoSara's reach across South Asia, targeting a $13 billion market and boosting access to rapid diagnostic solutions.
03-20 19:56
Co-Diagnostics Inc. schedules fourth-quarter and full-year 2025 earnings webcast
Co-Diagnostics Inc. schedules fourth-quarter and full-year 2025 earnings webcast Co-Diagnostics will release its fourth quarter and full year 2025 financial results on March 31, 2026, after the market close. The company will host a conference call and webcast on March 31, 2026 at 4:30 p.m. ET, with
03-17 21:04
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers iSpecimen (NASDAQ:ISPC) shares moved upwards by 70.7% to $0.38 during ...
03-13 05:05
Co-Diagnostics Granted Japanese Patent Titled 'Systems, Methods, And Apparatus For Automated Self-Contained Biological Analysis'
Co-Diagnostics, Inc. (NASDAQ:CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that the Japan Patent
03-12 21:15
Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies
SALT LAKE CITY, March 12, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the develo...
03-12 21:00
Co-Diagnostics Regains Nasdaq Compliance
Co-Diagnostics, Inc. (NASDAQ:CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that on March 9, 2026,
03-10 21:10
